Y. Ma et al. / Tetrahedron 76 (2020) 131474
5
v/v TMS) was used as solvent. 1H NMR spectra was reported in parts
per million using tetramethylsilane (TMS,
¼ 0.00 ppm) as an in-
7.36e7.32 (m, 3H), 7.27 (d, J ¼ 10.0 Hz, 1H), 7.20 (s,1H), 7.09 (d,
d
J ¼ 6.5 Hz, 2H), 5.42 (s, 2H). 13C NMR (125 MHz, CDCl3)
d 155.2,
ternal standard, and 13C NMR was calibrated at 77.2 ppm for the
chemical shift of the deuterated chloroform peak. The NMR data are
reported as follows: chemical shift (ppm), integration, multiplicity
(s ¼ singlet, d ¼ doublet, t ¼ triplet, q ¼ quad, m ¼ multiplicity,
br ¼ wide state) and coupling constant (Hz). High resolution mass
spectra (HRMS) were obtained with a FT-ICRMS. Thin layer chro-
matography (TLC) was performed on a glass plate coated with
GF254 silica gel and observed under 254 nm UV light, while column
chromatography was performed using silica gel HG/T2354-2010.
All reagents are analytically pure, purchased from commercial
suppliers and used directly unless further purification is indicated
otherwise. All reactions were performed at atmospheric pressure
and all reagent weighing was performed at room temperature in
air.
142.0, 136.9, 136.0, 130.3, 129.8, 129.4, 129.0, 128.9, 128.2, 126.1,
123.6, 121.0, 110.7, 48.7.
4.2.6. Methyl 4-(1-benzyl-1H-benzo[d]imidazole-2-yl)benzoate
Light yellow viscous liquid; 13% yield, 13.4 mg; 1H NMR
(500 MHz, CDCl3)
d
8.12 (d, J ¼ 8.0 Hz, 2H), 7.89 (d, J ¼ 8.5 Hz, 1H),
7.79e7.77 (d, J ¼ 7.5 Hz, 2H), 7.34e7.33 (m, 4H), 7.28e7.26 (m, 2H),
7.10 (d, J ¼ 7.0 Hz, 2H), 5.47 (s, 2H), 3.94 (s, 3H). 13C NMR (125 MHz,
CDCl3)
d 166.7, 153.1, 143.4, 136.5, 136.3, 134.6, 131.4, 130.1, 129.44,
129.35, 128.1, 126.1, 123.7, 123.2, 120.4, 110.8, 52.5, 48.7.
4.2.7. 1-(3-bromobenzyl)-2-phenyl-1H-benzo[d]imidazole (2g)
Light yellow solid; 62% yield, 67.6 mg; 1H NMR (500 MHz, CDCl3)
d
7.89 (s, 1H), 7.87 (d, J ¼ 6.5 Hz, 1H), 7.60 (d, J ¼ 8.0 Hz, 1H), 7.56 (d,
4.2. General method for the synthesis of benzimidazoles (2a-l)
J ¼ 7.5 Hz, 1H), 7.34e7.30 (m, 4H), 7.27e7.26 (m, 3H), 7.10 (d,
J ¼ 7.0 Hz, 2H), 5.45 (s, 2H). 13C NMR (125 MHz, CDCl3)
d 152.6,
Compounds 2a-l were synthesized by adding DDQ (0.72 mmol)
to o-phenylenediamine derivatives (1, 0.3 mmol) in 1.0 mL of
dimethyl sulfoxide at 40 ꢀC for 2 h. TLC was employed to monitor
the reaction. When N,N0-dialkyl o-phenylenediamine was con-
verted completely, saturate Na2S2O3 was dropped into reaction
mixture, and stirring was continued. Then the mixture was
extracted and evaporated, and the resulting residue was purified by
column chromatography on silica gel column using EtOAc-
petroleum ether solution as eluent to afford desired benzimid-
azole 2.
143.2,136.3,133.1,132.6,132.3,130.4,129.3,128.1,127.7,126.1,123.6,
123.09, 123.06, 120.4, 110.7, 48.6; HRMS (FT-ICR) m/z: [M þ H]þ
calcd for C20H15BrN2, 363.0491; found, 363.0480.
4.2.8. 1-Octyl-2-phenyl-1H-benzo[d]imidazole (2h) [18c]
Light yellow viscous liquid; 86% yield, 82.7 mg; 1H NMR
(500 MHz, CDCl3)
d
7.85 (d, J ¼ 5.5 Hz, 1H), 7.71 (dd, J1 ¼ 4.5 Hz,
J2 ¼ 2.0 Hz, 2H), 7.51 (s, 3H), 7.41 (t, J ¼ 3.0 Hz, 1H), 7.32 (s, 2H), 4.22
(t, J ¼ 7.0 Hz, 2H), 1.81 (s, 2H), 1.25e1.19 (m, 10H), 0.86 (t, J ¼ 6.5 Hz,
3H). 13C NMR (125 MHz, CDCl3)
d 153.6, 142.7, 135.4, 130.5, 129.9,
129.5, 128.8, 122.9, 122.6, 119.9, 110.3, 44.9, 31.8, 29.8, 29.1, 29.0,
26.8, 22.7, 14.2. HRMS (FT-ICR) m/z: [M þ H]þ calcd for C21H26N2,
307.2169; found, 307.2159.
4.2.1. 1-Benzyl-2-phenyl-1H-benzo[d]imidazole (2a) [18a]
White solid; 99% yield, 84.5 mg; 1H NMR (500 MHz, CDCl3)
d
7.87 (d, J ¼ 8.0 Hz, 1H), 7.69 (d, J ¼ 6.5 Hz, 2H), 7.49e7.44 (m, 3H),
7.35e7.28 (m, 4H), 7.24e7.20 (m, 2H), 7.11 (d, J ¼ 7.0 Hz, 2H), 5.46 (s,
2H). 13C NMR (125 MHz, CDCl3)
154.4, 143.4, 136.6, 136.3, 130.3,
4.2.9. 5-Methyl- and 6-methyl-1-octyl-2-phenyl-1H-benzo[d]
imidazole (2i, 2j)
d
130.1, 129.5,129.2,128.9,128.0,126.2,123.2,122.9,120.2,110.7, 48.6.
Light yellow viscous liquid; 56% yield, 56.2 mg; 1H NMR
(500 MHz, CDCl3)
d 7.68 (s, 5H), 7.61 (s, 1H), 7.49 (s, 6H), 7.28 (d,
4.2.2. 1-Benzyl-4-methyl-2-phenyl-1H-benzo[d]imidazole (2b)
J ¼ 8.0 Hz, 1H), 7.18 (s, 1H), 7.12 (d, J ¼ 7.0 Hz, 2H), 4.17 (s, 4H), 2.53
(s, 3H), 2.50 (s, 3H), 1.79 (s, 4H), 1.25e1.19 (m, 20H), 0.87e0.84 (m,
White solid; 56% yield, 50.1 mg; 1H NMR (500 MHz, CDCl3)
6H). 13C NMR (125 MHz, CDCl3)
d 153.8, 153.4, 143.6, 141.4, 136.0,
d
7.66 (d, J ¼ 6.5 Hz, 2H), 7.44 (d, J ¼ 6.5 Hz, 3H), 7.31e7.25 (m, 3H),
7.13e7.07 (m, 4H), 7.04 (d, J ¼ 7.5 Hz, 1H), 5.40 (s, 2H), 2.75 (s, 3H).
13C NMR (125 MHz, CDCl3)
153.7, 142.7, 136.7, 135.8, 130.5, 130.3,
133.9, 132.7, 132.0, 131.0, 129.7, 129.6, 129.43, 129.42, 128.8, 124.2,
124.0, 119.8, 119.6, 110.1, 109.8, 44.8, 44.7, 31.8, 29.84, 29.81, 29.2,
29.1, 26.8, 22.7, 22.1, 21.7, 14.2. HRMS (FT-ICR) m/z: [M þ H]þ calcd
for C22H28N2, 321.2325; found, 321.2315.
d
129.9, 129.6, 129.2, 128.9, 127.9, 126.2, 123.2, 123.1, 108.2, 48.5, 17.0.
4.2.3. 1-Benzyl-6-methyl-2-phenyl-1H-benzo[d]imidazole (2c)
4.2.10. 1-(Hex-5-en-1-yl)-2-phenyl-1H-benzo[d]imidazole (2k)
Light yellow viscous liquid; 23% yield, 15.5 mg; 1H NMR
White solid; 74% yield, 66.2 mg; 1H NMR (500 MHz, CDCl3)
d
7.74
(500 MHz, CDCl3)
d
7.84e7.83 (d, J ¼ 7.5 Hz, 1H), 7.70e7.68 (m, 2H),
(d, J ¼ 6.5 Hz, 1H), 7.67 (s, 2H), 7.45 (s, 3H), 7.34e7.32 (m, 3H),
7.52 (s, 2H), 7.46e7.41 (m, 1H), 7.33e7.32 (m, 2H), 7.26e7.20 (m,
1H), 5.74e5.66 (m, 1H), 4.94 (d, J ¼ 13.0 Hz, 2H), 4.24 (t, J ¼ 7.0 Hz,
2H), 2.00e1.99 (m, 2H), 1.85e1.82 (m, 2H), 1.37e1.34 (m, 2H). 13C
7.15e7.12 (m, 3H), 7.01 (s, 1H), 5.43 (s, 2H), 2.44 (s, 3H). 13C NMR
(125 MHz, CDCl3)
d 153.9, 141.5, 136.8, 136.6, 133.3, 130.4, 129.9,
129.4, 129.2, 128.9, 127.9, 126.1, 124.5, 119.7, 110.5, 48.4, 22.0.
NMR (125 MHz, CDCl3) d 153.9, 143.3, 138.0, 135.7, 130.9, 129.9,
129.5, 128.9, 122.5, 115.3, 110.2, 44.7, 33.1, 29.2, 26.0. HRMS (FT-ICR)
4.2.4. 1-Benzyl-5-chloro-2-phenyl-1H-benzo[d]imidazole (2d)
m/z: [M þ H]þ calcd for C19H20N2, 277.1699; found, 277.1691.
Light yellow solid; 22% yield, 21.0 mg; 1H NMR (500 MHz, CDCl3)
4.3. Procedure for synthesis of benzimidazole (2m-q)
d
7.84 (s, 1H), 7.68 (d, J ¼ 4.0 Hz, 2H), 7.47 (m, 3H), 7.34 (m, 3H), 7.20
(d, J ¼ 8.5 Hz, 1H), 7.10 (m, 3H), 5.45 (s, 2H). 13C NMR (125 MHz,
To a round bottom flask that was equipped with a stirring bar,
corresponding monosubstituted o-phenylenediamine (0.3 mmol)
and ethanol (10.0 mL) were added successively and the resulting
mixture was stirred thoroughly for 10 min, followed by addition of
acetic acid (0.2 mL) and corresponding aldehydes (0.3 mmol, 1.0
equiv) to the dispersion solution in turn, and refluxed at 80 ꢀC for
2 h. After completion of the reaction, the reaction mixture was
cooled to room temperature and monitored by TLC. Then the
CDCl3)
d 155.6, 144.2, 136.1, 134.8, 130.4, 129.9, 129.4, 129.3, 129.0,
128.5, 128.2, 126.1, 123.6, 120.0, 111.5, 48.7.
4.2.5. 1-Benzyl-6-chloro-2-phenyl-1H-benzo[d]imidazole (2d’)
Light yellow solid; 66% yield, 63.1 mg; 1H NMR (500 MHz, CDCl3)
d
7.77 (d, J ¼ 8.5 Hz, 1H), 7.67 (d, J ¼ 2.0 Hz, 2H), 7.49e7.46 (m, 3H),